Arcus Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCUS and other ETFs, options, and stocks.

About RCUS

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer.

CEO

Terry J. Rosen

CEOTerry J. Rosen

Employees

627

Employees627

Headquarters

Hayward, California

HeadquartersHayward, California

Founded

2015

Founded2015

Employees

627

Employees627

RCUS Key Statistics

Market cap

906.38M

Market cap906.38M

Price-Earnings ratio

-2.05

Price-Earnings ratio-2.05

Dividend yield

—

Dividend yield—

Average volume

1.32M

Average volume1.32M

High today

$8.74

High today$8.74

Low today

$8.32

Low today$8.32

Open price

$8.39

Open price$8.39

Volume

644.66K

Volume644.66K

52 Week high

$18.98

52 Week high$18.98

52 Week low

$6.50

52 Week low$6.50

Analyst ratings

85%

of 13 ratings

Buy

84.6%

Hold

15.4%

Sell

People also own

Based on the portfolios of people who own RCUS. This list is generated using Robinhood data, and it’s not a recommendation.